AKAN
Akanda Corp.
$11.42
-0.69 (-5.70%)
At close · Jul 7
Market Cap
$6.18M
Shares
540,841
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$11.42
Open$11.36
Day$10.80–11.90
52W$2.30–209.23
Avg vol 30d360K
Short int140K · 25.9% float · 1.0d
Short vol25%
DataMar 2022–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
Technical · trend & momentum
Strong Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−47% below
−
Price vs 50-day avg
−45% below
◦
RSI (14)
37 · neutral
−
MACD trend
negative
−
52-week position
4% · near low
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $21 › 200d $21 — 200d above 50d
+
Institutional flow
+400% holders QoQ · +5 funds added
◦
Insider flow
No net insider activity over 90 days
−
Short interest
25.86% of float · ▲ +84.5% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
5 holders — 13F breadth
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−47% below
Bearish
Price vs 50-day avg
−45% below
Bearish
RSI (14)
37 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
4% · near low
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $21 › 200d $21 — 200d above 50d
Institutional flow
Accumulating
+400% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
25.86% of float · ▲ +84.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $2
Now $11 · 4%
52-wk high $209
vs 200-day avg -47%
vs 50-day avg -45%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AKAN
this stock
Akanda Corp.
|
$6.18M | +11.0% | — | — | 25.9% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.59B | +8.8% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$51.21B | +5.2% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.33B | -2.7% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
5
- % held
- 8.5%
- Net QoQ
- +46.1K sh
- Top holder
- CONTINUUM WEALTH ADVISORS…
Held
Float
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AKAN | -16.4% | -26.9% | -3.6% | -16.7% | +11.0% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -17.3% | -28.3% | -11.2% | -16.8% | +1.3% |